Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Cash & Current Investments (2020 - 2025)

Tango Therapeutics has reported Cash & Current Investments over the past 6 years, most recently at $112.7 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $112.7 million for Q4 2025, down 56.31% from a year ago — trailing twelve months through Dec 2025 was $112.7 million (down 56.31% YoY), and the annual figure for FY2025 was $112.7 million, down 56.31%.
  • Cash & Current Investments for Q4 2025 was $112.7 million at Tango Therapeutics, down from $152.8 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for TNGX hit a ceiling of $503.8 million in Q3 2021 and a floor of $39.7 million in Q2 2025.
  • Median Cash & Current Investments over the past 5 years was $129.1 million (2021), compared with a mean of $195.1 million.
  • Biggest five-year swings in Cash & Current Investments: surged 203565.03% in 2021 and later plummeted 87.68% in 2025.
  • Tango Therapeutics' Cash & Current Investments stood at $145.6 million in 2021, then crashed by 58.42% to $60.5 million in 2022, then grew by 11.15% to $67.3 million in 2023, then soared by 283.32% to $257.9 million in 2024, then tumbled by 56.31% to $112.7 million in 2025.
  • The last three reported values for Cash & Current Investments were $112.7 million (Q4 2025), $152.8 million (Q3 2025), and $39.7 million (Q2 2025) per Business Quant data.